Body composition analyzer - lrmc

Ended Purchase Order Awarded Last action

Contract number
W9114F25PA065
Awardee
Awarding agency
Obligated
$35,705

Award facts

Opportunity
Contract value 100% obligated
$35,705.00 Current and potential, with all options
Completion date 100% complete
  • Current, with exercised options
  • Potential, with all options
Contracting staff
Funding agency
Defense Health Agency Department of Defense
NAICS code
339112 Surgical and Medical Instrument Manufacturing
PSC
6515 Medical And Surgical Instruments, Equipment, And Supplies
Set-aside
No set-aside
Competition
Competed under SAP · 9 offers Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Germany

Award details come from SAM.gov/FPDS.

About this award

The Defense Health Agency has awarded a $35,705 firm fixed-price purchase order to Biospace, Inc. (doing business as Inbody) for the procurement of two InBody 770 Body Composition Analyzers destined for the Landstuhl Regional Medical Center in Germany. The award, issued on August 28, 2025, with an ultimate completion date of November 28, 2025, resulted from a competitive solicitation posted by the Department of the Army Medical Command through the U.S. Army Medical Readiness Contracting Office-Europe. The analyzers must meet specific technical requirements including multifrequency bioelectrical impedance analysis capability (1–1000 kHz), test completion within 60 seconds, weight accommodation between 20–590 pounds, and 220VAC@50Hz electrical compatibility, with delivery required within 60 calendar days of award. The procurement was evaluated using Lowest Price Technically Acceptable (LPTA) criteria under simplified acquisition procedures and does not utilize a set-aside designation.

Biospace, Inc., a Cerritos, California-based minority-owned and Asian-Pacific American-owned company specializing in body composition analysis technology, was selected as the prime contractor. The company has an established track record supplying body composition analyzers to federal health and military agencies, including the Department of Veterans Affairs, Department of the Army, Navy, Air Force, Marine Corps, Special Operations Command, and the Defense Health Agency. Biospace maintains multiple federal contract vehicles including a General Services Administration Multiple Award Schedule contract and an Indefinite-Delivery/Indefinite-Quantity Medical Equipment and Supplies Federal Supply Schedule agreement with the Department of Veterans Affairs, which facilitate efficient procurement of its innovative medical devices across government organizations.

Quick answers

Who was awarded contract W9114F25PA065?

W9114F25PA065 was awarded to Biospace, Inc. by Medical Command (Department of the Army) on August 28, 2025.

How much is contract W9114F25PA065 worth?

The government has obligated $35,705 on W9114F25PA065.

Which agency awarded contract W9114F25PA065?

Medical Command (Department of the Army) awarded W9114F25PA065, with funding from Defense Health Agency (Department of Defense).

Was contract W9114F25PA065 competed?

The extent of competition for W9114F25PA065 was competed under sap. The government received 9 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award